ABANZA Selected for the MedTech Innovator 2026 Mid-Stage Accelerator Cohort

Selected for MedTech Innovator's Mid-Stage Accelerator

ABANZA has been selected to join the Mid-Stage cohort of MedTech Innovator, the world's largest accelerator for medical device companies.

We are honored to be among the 18 companies selected for MedTech Innovator's flagship Mid-Stage accelerator program, within a broader group of 65 companies chosen from 1,835 global applicants — the top 1%.

A Recognition of Our Team and Technology

This recognition reflects the hard work of our team and the impact of our soft tissue fixation technology platform, including QuadLock™ and WasherCap™, as we continue leading the evolution of Sports Medicine for today's changing patient population.

Thank you to MedTech Innovator and to everyone supporting ABANZA on this journey.

Read the official announcement: MedTech Innovator Unveils 65 Startups in its 2026 Accelerator Cohort.